Holen Sie sich die Stockscreener-App
1.46
0.00%
0.00
Handel nachbörslich:
1.48
0.02
+1.37%
Schlusskurs vom Vortag:
$1.46
Offen:
$1.5
24-Stunden-Volumen:
209.02K
Relative Volume:
0.80
Marktkapitalisierung:
$31.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.32M
KGV:
-3.0316
EPS:
-0.4816
Netto-Cashflow:
$-7.43M
1W Leistung:
+19.67%
1M Leistung:
+44.55%
6M Leistung:
-23.16%
1J Leistung:
+15.77%
1-Tages-Spanne:
$1.43
$1.58
1-Wochen-Bereich:
$1.19
$1.58
52-Wochen-Spanne:
$0.85
$2.2299
NanoViricides Inc Stock (NNVC) Company Profile
Firmenname
NanoViricides Inc
Sektor
Branche
Telefon
203-937-6137
Adresse
1 Controls Drive, Shelton, CT
Compare NNVC vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NNVC
NanoViricides Inc
|
1.46 | 31.53M | 0 | -8.32M | -7.43M | -0.4816 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
NanoViricides Inc Stock (NNVC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-16 | Eingeleitet | Alliance Global Partners | Buy |
| 2015-02-11 | Eingeleitet | Midtown Partners | Strong Buy |
NanoViricides Inc Aktie (NNVC) Neueste Nachrichten
NanoViricides, Inc. Announces Participation in the D. Boral Capital Global Conference - Oil & Gas 360
NanoViricides to attend D Boral Capital Conference - Proactive financial news
NanoViricides management offers investor meetings in New York May 7 - Stock Titan
NanoViricides’ Measles Treatment Granted Orphan Drug Designation by FDA - Yahoo Finance
NanoViricides’ NV-387 Receives FDA Orphan Drug Designation for Measles Treatment - citybuzz -
NanoViricdes Surges on Winning ODD Status - Baystreet.ca
NNVC Stock Up 17% Today: What’s Driving The Rally? - Stocktwits
NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA - Lelezard
NanoViricides antiviral drug NV-387 wins FDA Orphan Drug Designation for measles treatment - Yahoo Finance
FDA orphan tag gives NanoViricides measles drug tax credits, fee waiver - Stock Titan
Is NanoViricides (NNVC) stock forming a clear pattern | Q1 2026: Profit Exceeds ViewsDividend Safety - Newser
NNVC Forecast, Price Target & Analyst Ratings | NANOVIRICIDES INC (NYSEARCA:NNVC) - ChartMill
NNVC Stock Price, Quote & Chart | NANOVIRICIDES INC (NYSEARCA:NNVC) - ChartMill
NNVC (NanoViricides Inc.) beats Q1 2026 EPS estimates by 23 percent, but posts a slight post-earnings share decline. - Cổng thông tin điện tử tỉnh Tây Ninh
NNVC NanoViricides exceeds Q1 2026 EPS estimates by 23 percent, but shares drop 4.89 percent on zero quarterly revenue.Trading Community - UBND thành phố Hải Phòng
NanoViricides says NV-387 could address measles outbreaks as cases rise globally - Yahoo Finance
Deadly Measles Cases Accentuate the Need for a - One News Page
Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides - ACCESS Newswire
NanoViricides to Present at the 15th Annual BIO-CEO Conference in NYC Tomorrow - AOL.com
Profit Recap: Can NanoViricides Inc continue delivering strong returns2026 Volatility Report & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
NanoViricides seeks FDA’s rare pediatric disease designation for antiviral candidate NV-387ICYMI - Proactive financial news
Macro Review: Should I hold or sell GMREPRA now2026 Spike Watch & Community Consensus Stock Picks - baoquankhu1.vn
Weekly Earnings: Is NanoViricides Inc subject to activist investor interestTake Profit & Real-Time Buy Signal Notifications - baoquankhu1.vn
Aug Summary: Is NanoViricides Inc undervalued by DCF analysisWeekly Gains Report & Stock Timing and Entry Methods - baoquankhu1.vn
NanoViricides files for Rare Pediatric Disease Designation for Measles Drug - Proactive financial news
Growth Value: Can NanoViricides Inc stock double in the next year2026 Technical Overview & Short-Term Trading Alerts - baoquankhu1.vn
Can NanoViricides (NNVC) Stock Go Higher | Price at $1.15, Up 6.48%Day Trade - Newser
Activity Recap: Is NanoViricides Inc forming a bullish divergencePortfolio Value Report & Short-Term Swing Trade Alerts - baoquankhu1.vn
NanoViricides Seeks Rare Pediatric Disease Designation for Measles Treatment Candidate - citybuzz -
Measles Rare Pediatric Disease Drug Designation Application File - GuruFocus
NanoViricides seeks rare pediatric disease status for measles drug NV-387 - Yahoo Finance
About Us - FinancialContent
Aug Shorts: Is NanoViricides Inc forming a breakout pattern2026 Earnings Impact & Short-Term Swing Trade Alerts - baoquankhu1.vn
NNVC Stock Analysis: NanoViricides Inc Biotech Stock Post 2.55% Daily Dip At $0.93 Level - Xã Vĩnh Công
Can NanoViricides (NNVC) Stock Recover Now | Price at $0.93, Down 2.11%Social Investment Platform - Newser
Small caps wrap: Alvopetro Energy, NanoViricides, New Era Energy & Digital, Digi Power X… - proactiveinvestors.co.uk
NanoViricides to Begin Phase II MPox Clinical Trial in Democratic Republic of Congo - citybuzz -
Small cap wrap: Alvopetro Energy, NanoViricides, New Era Energy & Digital, Digi Power X… - Proactive financial news
NanoViricides to begin Phase II trial of MPox treatment in Congo - Proactive financial news
Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides - ACCESS Newswire
Monkeypox drug trial cleared in Congo as NanoViricides readies dosing - Stock Titan
Finanzdaten der NanoViricides Inc-Aktie (NNVC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.77%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):